Unlocking the Potential of Non-Invasive Oral Therapies to Improve Patient Compliance and Overcome the Limitations of Intravitreal Delivery
Time: 2:00 pm
day: Day1
Details:
- Assessing preclinical and clinical evidence supporting reducing vitamin A delivery to the eye as a therapeutic strategy to slow geographic atrophy progression
- Exploring Stargardt disease as a juvenile macular degeneration disease model or geographic atrophy
- Exploring opportunities for earlier treatment targeting intermediate AMD
